This service is provided by Limbix Health, Inc.
Information Collection and Use; Choice and Consent
Uses and Disclosures
Participants must be registered on the Service and have an active account in order to use the Service. We receive PII about Participants directly from Participants or their legal guardians in order to establish an account and for you to be able to register for and use the Service and identify you as an authorized Participant. Limbix may collect PII when Participants are registered by Administrators and gain access to the App, Site, or Service. When registering, we collect your email address, phone number and password. We will also collect limited PII from your legal guardian (if applicable) to complete the consent process. When you use the App or Site, we may also collect information from you regarding your medical history, medication list, symptoms, and usage of the Service. It is always your choice whether or not to provide us with such information. Limbix uses PII and information you provide to us through the App, the Site, and the Service:
a. To run the Limbix Spark study (for example, Limbix may use or disclose PII for the purpose of allowing research staff or study clinicians to ensure your safety or to remind you to complete certain study-related tasks);
b. To communicate with you or your legal guardian, for example to reset password or reminders;
c. To communicate with regulatory bodies, such as the Institutional Review Board (IRB) or Food and Drug Administration (FDA), that are overseeing Limbix Spark research.
d. To communicate with individuals that can help you if you should threaten to harm yourself or others. If keeping information obtained during the study private would immediately put you or others in danger, we will release that information.
d. For payment – we may use/disclose your information for the purpose of paying you for your participation in the study.
e. To create user profiles;
f. To create de-identified analytical information about the effectiveness of the Services;
g. To reply to your request for information or comments.
Authorization for Disclosures to Third Parties
You may withdraw from the Limbix Spark study at any time, which will terminate future collection of PII. Data already collected during the study will be maintained and used for research purposes in accordance with FDA regulations. If you wish to access, amend, or modify your information in any way, please discuss this change with an Administrator.
Protecting Your Information
Limbix uses secure server software (SSL), firewalls, and end-to-end encryption to protect your PIIfrom unauthorized access, disclosure, alteration, or destruction. All PII is transmitted, stored, and processed in a secure environment. However, no method of transmission over the Internet, or method of electronic storage, is 100% secure. Therefore, we cannot guarantee its security. We will retain PII during the collection and processing of study results, but in no case later than six (6) years following the end of the study or withdrawal of your consent, unless otherwise required by regulatory bodies. We will retain and use PII as necessary to comply with our legal obligations, resolve disputes, and enforce our agreements.
Information Sharing and Disclosure
Your PII may be shared with individuals and organizations that conduct or watch over this research, including:
● The research sponsor
● People who work with the research sponsor
● Government agencies, such as the Food and Drug Administration
● The Institutional Review Board (IRB) that reviewed this research
Links to Other Sites; Third Party Apps; Transactions with Third Parties
Children under 13 years of age
Our Service is intended for individuals who are 13 years old or older. If you believe someone who is under age 13 has used the Service and entered personal information, please contact us using one of the options provided below.
Your California Privacy Rights; California Do Not Track Disclosures
If you are a California resident, California Civil Code Section 1798.83 permits you to request information regarding the disclosure of your personal information, as defined in California Civil Code Section 1798.83(e) (7), by Limbix or its subsidiaries to a third party for the third party’s direct marketing purposes. Because we do not make such disclosures, we are exempt from these reporting requirements. Your browser may offer you a “Do Not Track” option, which allows you to signal to operators of websites and web applications and services (including behavioral advertising services) that you do not wish such operators to track certain of your online activities, over time and across different websites. We do not honor “Do Not Track” signals.
Accessing Your Information
Administrators may access, review, change, or update your PII through the Site, and you should speak to an Administrator to make changes on your behalf. You may reset your password through the App by following the password reset instructions.
Limbix commits to resolving complaints about your privacy and our collection or use of your PII. If you believe your privacy rights have been violated or you disagree with any action Limbix has taken with regard to your PII, you may file a complaint with Limbix by emailing us at firstname.lastname@example.org. Limbix will not take any action against you for making a complaint.
Limbix Health, Inc.
Attn: Security Official
839 Emerson Street
Palo Alto, CA 94301